Cancer of the small bowel is a rare entity but its incidence is rising. Historically, outcome is poor despite apparent curative resection. At present surgery remains the only treatment modality of proven benefit in the management of this disease. Recent data would suggest 5βyear survival rates in th
Adenocarcinoma of the small bowel in Lynch syndrome II
β Scribed by Henry T. Lynch; Thomas C. Smyrk; Patrick M. Lynch; Stephen J. Lanspa; Bruce M. Boman; Julie Ens; Jane F. Lynch; Patty Strayhorn; Thomas Carmody; Giuseppe Cristofaro
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 669 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Adenocarcinoma of the small bowel is rare and accounts for about 1% of all gastrointestinal tract cancer. This disorder has been identified in association with Crohn's disease, celiac disease, Peutz-Jegher's syndrome, and familial adenomatous polyposis. We report adenocarcinoma of the small bowel in nine patients from eight Lynch syndrome 11 extended pedigrees. Each affected patient was in the direct genetic lineage or manifested multiple primary cancers (stomach, colon, endometrium, and ovary) consonant with the tumor spectrum of Lynch syndrome 11. The average age of onset for small bowel cancer was 47 years (range 31 to 56 years), versus the general population peak occurrence after the sixth decade. We conclude that small bowel cancer may be an integral component of the tumor spectrum of Lynch syndrome 11.
π SIMILAR VOLUMES